Trials / Unknown
UnknownNCT02857530
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Tianjin Medical University General Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy and Safety of Recombinant human thrombopoietin in patients with severe aplastic anemia and very severe aplastic anemia, a randomized, double-blind, placebo-controlled, II phase, multi-center clinical research.
Detailed description
rhTPO
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rhTPO | rhTPO |
| DRUG | placebo | without rhTPO |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2019-07-01
- Completion
- 2020-07-01
- First posted
- 2016-08-05
- Last updated
- 2016-08-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02857530. Inclusion in this directory is not an endorsement.